Free Trial

Kestra Medical Technologies (KMTS) Competitors

Kestra Medical Technologies logo
$15.67 +0.42 (+2.75%)
As of 01:00 PM Eastern

KMTS vs. NVST, PRCT, LIVN, WRBY, NVCR, LMAT, ENOV, EYE, CNMD, and AORT

Should you be buying Kestra Medical Technologies stock or one of its competitors? The main competitors of Kestra Medical Technologies include Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), Enovis (ENOV), National Vision (EYE), CONMED (CNMD), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

Kestra Medical Technologies vs. Its Competitors

Kestra Medical Technologies (NASDAQ:KMTS) and Envista (NYSE:NVST) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

Kestra Medical Technologies presently has a consensus target price of $27.50, indicating a potential upside of 75.49%. Envista has a consensus target price of $20.23, indicating a potential downside of 0.78%. Given Kestra Medical Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe Kestra Medical Technologies is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kestra Medical Technologies
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33

In the previous week, Kestra Medical Technologies had 1 more articles in the media than Envista. MarketBeat recorded 5 mentions for Kestra Medical Technologies and 4 mentions for Envista. Envista's average media sentiment score of 0.45 beat Kestra Medical Technologies' score of 0.36 indicating that Envista is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Kestra Medical Technologies
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Envista
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Kestra Medical Technologies has higher earnings, but lower revenue than Envista.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kestra Medical TechnologiesN/AN/AN/AN/AN/A
Envista$2.50B1.38-$1.12B-$6.53-3.12

Kestra Medical Technologies has a net margin of 0.00% compared to Envista's net margin of -44.90%. Envista's return on equity of 4.07% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Kestra Medical TechnologiesN/A N/A N/A
Envista -44.90%4.07%2.25%

Summary

Kestra Medical Technologies and Envista tied by winning 5 of the 10 factors compared between the two stocks.

Get Kestra Medical Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for KMTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KMTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KMTS vs. The Competition

MetricKestra Medical TechnologiesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$804.65M$10.34B$5.50B$9.01B
Dividend YieldN/A2.09%5.39%4.11%
P/E RatioN/A16.7627.4220.07
Price / SalesN/A29.50398.50109.13
Price / CashN/A22.7836.1356.90
Price / BookN/A3.678.015.70
Net IncomeN/A$235.40M$3.16B$248.47M
7 Day Performance-12.46%2.09%2.08%2.92%
1 Month Performance-20.17%4.05%4.38%5.77%
1 Year PerformanceN/A-9.87%35.81%21.39%

Kestra Medical Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KMTS
Kestra Medical Technologies
N/A$15.67
+2.8%
$27.50
+75.5%
N/A$804.65MN/A0.00300
NVST
Envista
3.6032 of 5 stars
$19.87
+1.1%
$20.23
+1.8%
+23.5%$3.37B$2.51B-3.0412,300
PRCT
PROCEPT BioRobotics
2.2141 of 5 stars
$58.63
flat
$90.00
+53.5%
-7.9%$3.23B$224.50M-34.29430News Coverage
LIVN
LivaNova
2.9286 of 5 stars
$45.80
+0.0%
$59.29
+29.4%
-12.9%$2.51B$1.25B-11.252,900
WRBY
Warby Parker
2.1251 of 5 stars
$21.57
+0.4%
$22.88
+6.0%
+37.0%$2.26B$771.32M-179.883,780
NVCR
NovoCure
3.7155 of 5 stars
$17.34
+1.4%
$32.83
+89.4%
+6.4%$1.93B$605.22M-11.461,488
LMAT
LeMaitre Vascular
2.3684 of 5 stars
$82.85
+0.5%
$97.83
+18.1%
+3.3%$1.87B$219.86M41.77490
ENOV
Enovis
3.5611 of 5 stars
$32.27
+0.0%
$58.00
+79.7%
-25.2%$1.84B$2.11B-2.327,367
EYE
National Vision
2.4419 of 5 stars
$23.22
+0.7%
$18.67
-19.6%
+93.6%$1.84B$1.82B-70.6713,411Positive News
CNMD
CONMED
4.6677 of 5 stars
$52.67
+0.6%
$62.20
+18.1%
-19.1%$1.63B$1.31B13.833,900News Coverage
AORT
Artivion
2.4695 of 5 stars
$30.82
+0.7%
$32.00
+3.8%
+20.6%$1.31B$388.54M-61.551,600Positive News

Related Companies and Tools


This page (NASDAQ:KMTS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners